Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > REACH chief: Companies 'failing to properly register chemicals'

Abstract:
European companies are not fully complying with new EU regulation on chemicals (REACH), said the executive director of the European Chemicals Agency (ECHA), Geert Dancet, in an interview with EurActiv.

REACH chief: Companies 'failing to properly register chemicals'

Europe | Posted on May 6th, 2009

Many companies not only submit incomplete REACH registration dossiers, but they also try to list several substances in one file and fail to be precise enough over the exact composition of their substances, Dancet said.

While the review process of the first REACH registrations is still underway, ECHA has already identified some systemic problems in the dossiers submitted.

One of the most important lessons learnt was the need to prevent companies from registering many substances in one file, Dancet told EurActiv. "There can only be a registration for one substance. You cannot take a group of substances and register them as one," he said.

Furthermore, not all registrations so far have complied "with all technical rules," said Dancet. He said companies did not seem to understand "the business rules we apply in checking the files".

Dancet also stressed that many of the dossiers were not good enough and needed to be sent back, because companies were having difficulty writing down the exact composition of a substance, and thus "don't clearly distinguish which substances we are talking about".

Meanwhile, ECHA is urging companies to establish so-called 'Substance Information Exchange Forums' (SIEFsexternal ) to share information, avoid double testing and allow the lead registrants to prepare joint registrations.

After over 2.7 million pre-registrations for some 146,000 different substances - some 20 times more than expected by the Commission - ECHA expects some 55,000 substances to be registered by 2010. While 80% of all SIEFs feature between 10 and 99 companies, less than 10% of these forums have appointed lead registrants so far.

"It is very important for companies to actually organise themselves" to make sure that the lead registrant files the dossier "not just a few days in advance," to make sure that ECHA is able to check it "before the others register," Dancet said.

He underlined that companies "have every interest in making sure that the timing of the joint registration is really well coordinated". Indeed, if the dossier is technically incomplete, companies "will have to withdraw their products from the market until they have made a complete registration," said Dancet.

As for overall enforcement of REACH legislation and implementation rules, "the enforcement laws can be extremely difficult" as they are national and thus "not necessarily the same," said Dancet. What constitutes a grave mistake or non-compliance in one country may only be average non-compliance in another, he added.

In addition, not all member states have adopted enforcement rules yet. The European Commission is still awaiting notification of national REACH enforcement provisions from Austria, Belgium, Spain, Italy, Luxembourg, Latvia and Portugal.

####

For more information, please click here

Copyright © European Commission

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Safety-Nanoparticles/Risk management

Scientists propose non-animal tools for assessing the toxicity of nanomaterials: Particle and Fibre Toxicology publishes recommendations from expert group meeting April 26th, 2016

The impact of anti-odor clothing on the environment March 31st, 2016

SUNY Poly, in Collaboration with the George Washington School of Medicine and Health Sciences and Stony Brook University, Demonstrates Pioneering Method to Visualize and Identify Engineered Nanoparticles in Tissue March 25th, 2016

Microagents with revolutionary potential March 24th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic